The FAT EMULSION INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: BAG, protective_storage_feature: DO NOT FREEZE, primary_container_content_quantity: 1000.0 MILLILITERS, active_medicament_medicinal_strength: 20.0 PERCENTAGE SOYBEAN OIL ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: INTRALIPID 20 PCT FAT EMULSION 1000ML 6S. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System under NSN 6505-01-597-6656, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | 20 PCT FAT EMULSION INJECTION; 1000 ML BAG; DO NOT STORE ABOVE 25 C (77 F); DO NOT FREEZE; FOR USE AS A PARENTERAL NUTRITION SOLUTION (PER 10 GRAMS LLIPIDS); PACKAGE OF 6 BAGS G |
| primary_container_type | BAG |
| protective_storage_feature | DO NOT FREEZE |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 1000.0 MILLILITERS |
| active_medicament_medicinal_strength | 20.0 PERCENTAGE SOYBEAN OIL ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | INTRALIPID 20 PCT FAT EMULSION 1000ML 6S |
| NSN | 6505-01-597-6656 |
| PROTECTIVE STORAGE FEATURE | DO NOT FREEZE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INTRALIPID 20 PCT FAT EMULSION 1000ML 6S |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.0 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 20.0 PERCENTAGE SOYBEAN OIL ACTIVE INGREDIENT |
| ADMINISTRATION | INTRAVENOUS |
| SPECIAL FEATURES | 20 PCT FAT EMULSION INJECTION; 1000 ML BAG; DO NOT STORE ABOVE 25 C (77 F); DO NOT FREEZE; FOR USE AS A PARENTERAL NUTRITION SOLUTION (PER 10 GRAMS LLIPIDS); PACKAGE OF 6 BAGS G |
| PRIMARY CONTAINER TYPE | BAG |